- Home
- CNTX vs AMTX Comparison
CNTX vs AMTX Comparison
Compare CNTX & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- AMTX
- Stock Information
- Founded
- CNTX 2015
- AMTX 2005
- Country
- CNTX United States
- AMTX United States
- Employees
- CNTX N/A
- AMTX N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- AMTX Major Chemicals
- Sector
- CNTX Health Care
- AMTX Industrials
- Exchange
- CNTX Nasdaq
- AMTX Nasdaq
- Market Cap
- CNTX 78.0M
- AMTX 90.3M
- IPO Year
- CNTX 2021
- AMTX N/A
- Fundamental
- Price
- CNTX $0.58
- AMTX $1.70
- Analyst Decision
- CNTX Strong Buy
- AMTX Strong Buy
- Analyst Count
- CNTX 4
- AMTX 4
- Target Price
- CNTX $6.00
- AMTX $13.18
- AVG Volume (30 Days)
- CNTX 164.6K
- AMTX 1.1M
- Earning Date
- CNTX 05-07-2025
- AMTX 05-08-2025
- Dividend Yield
- CNTX N/A
- AMTX N/A
- EPS Growth
- CNTX N/A
- AMTX N/A
- EPS
- CNTX N/A
- AMTX N/A
- Revenue
- CNTX N/A
- AMTX $237,892,000.00
- Revenue This Year
- CNTX N/A
- AMTX $31.76
- Revenue Next Year
- CNTX N/A
- AMTX $86.51
- P/E Ratio
- CNTX N/A
- AMTX N/A
- Revenue Growth
- CNTX N/A
- AMTX N/A
- 52 Week Low
- CNTX $0.49
- AMTX $1.22
- 52 Week High
- CNTX $2.75
- AMTX $4.73
- Technical
- Relative Strength Index (RSI)
- CNTX 33.91
- AMTX 53.16
- Support Level
- CNTX $0.49
- AMTX $1.64
- Resistance Level
- CNTX $0.71
- AMTX $1.80
- Average True Range (ATR)
- CNTX 0.08
- AMTX 0.10
- MACD
- CNTX -0.02
- AMTX 0.01
- Stochastic Oscillator
- CNTX 33.31
- AMTX 54.02
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.